Page 264 - Sách năm 2022 - Fulltext - hieu final

1. “Chẩn đoán và điều trị suy tim cấp và suy tim mạn”, Khuyến cáo của Hội tim mạch quốc gia Việt
Nam năm 2022.
2. Lê Ngọc Lan Thanh (2016), "Khảo sát tình hình điều trị suy tim tâm thu theo khuyến cáo ACC
2013", Luận văn Thạc sĩ Y học, Đại học Y Dược thành phố Hồ Chí Minh.
3. Nguyễn Ngọc Mai, Trần Kim Trang (2016), "Tình trạng thiếu sắt ở bệnh nhân suy tim mạn", Luận
văn Thạc sĩ Y học, Đại học Y Dược TP. Hồ Chí Minh.
4. Nguyễn Hồng Thoại, Trần Kim Trang (2018), "Thiếu sắt ở bệnh nhân suy tim mạn", Luận văn Thạc
sĩ Y học, Đại học Y Dược thành phố Hồ Chí Minh.
5. Theresa McDonagh, Marco Metra, Marianna Adamo, Roy S Gardner, Andreas
Baumbach, Michael Böhm, Haran Burri, Javed Butler, JelenaČelutkienė, Ovidiu Chioncel, ”2021
ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by
the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European
Society of Cardiology (ESC) With the special contribution of the Heart Failure Association
(HFA) of the ESC”, European Heart Journal, Volume 42, Issue 36, 21 September 2021, Pages
3599–3726.
6. Tsao CW, Lyass A, Enserro D et al. emporal Trends in the Incidence of and Mortality Associated
With Heart Failure With Preserved and Reduced Ejection Fraction. JACC Heart Fail. 2018
Aug;6(8):678-685.
7. Cohen-Solal A., Leclercq C., Deray G., Lasocki S., Zambrowski J. J., et al. (2014), "Iron deficiency:
an emerging therapeutic target in heart failure". Heart, 100 (18), pp. 1414-20.
8. Brouwers FP, de Boer RA, van der Harst et al. Incidence and epidemiology of new onset heart
failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up
of PREVEND. Eur Heart J (2013) 34, 1424–1431
9. Reyes EB, Ha JW, Firdaus I et al. Heart failure across Asia: Same healthcare burden but
differences in organization of care. Int J Cardiol. 2016 Nov 15;223:163-167
10. Jankowska E. A., Rozentryt P., Witkowska A., Nowak J., Hartmann O., et al. (2010), "Iron
deficiency: an ominous sign in patients with systolic chronic heart failure", Eur Heart J, 31 (15),
pp. 1872-80.
11. Jankowska E. A., Rozentryt P., Witkowska A., Nowak J., Hartmann O., et al. (2011), "Iron
deficiency predicts impaired exercise capacity in patients with systolic chronic heart failure", J
Card Fail, 17 (11), pp. 899-906.
12. Klip I. T., Comin-Colet J., Voors A. A., Ponikowski P., Enjuanes C., et al. (2013), "Iron
deficiency in chronic heart failure: an international pooled analysis", Am Heart J, 165 (4), pp.575-
582.e3.
13. Enjuanes C., Klip I. T., Bruguera J., Cladellas M., Ponikowski P., et al. (2014), "Iron deficiency
and health-related quality of life in chronic heart failure: results from a multicenter European
study", Int J Cardiol, 174 (2), pp. 268-275.
14. Okonko D. O., Mandal A. K., Missouris C. G., Poole-Wilson P. A. (2011), "Disordered iron
homeostasis in chronic heart failure: prevalence, predictors, and relation to anemia, exercise
capacity, and survival", J Am Coll Cardiol, 58 (12), pp. 1241-1251.
15. Parikh A, Natarajan S, Lipsitz SR, Katz SD., “Iron deficiency in community-dwelling US adults
with self-reported heart failure in the National Health and Nutrition Examination Survey III:
prevalence and associations with anemia and inflammation”, Circ Heart Fail. 2011Sep;4(5):599-
606.
16. Yeo, Tee Joo, et al. "Iron deficiency in a multi‐ethnic Asian population with and without heart
failure: prevalence, clinical correlates, functional significance and prognosis", European journal of
heart failure , (2014): 1125-1132.
17. Ponikowski P, et al. Rationale and design of the AFFIRM-AHF trial: a randomised, double-blind,
placebo-controlled trial comparing the effect of intravenous ferric carboxymaltose on
hospitalisations and mortality in iron-deficient patients admitted for acute heart failure. Eur J Heart
Fail ,2019; 21: 1651–1658.

264